- Home
- AMD vs ABBV Comparison
AMD vs ABBV Comparison
Compare AMD & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMD
- ABBV
- Stock Information
- Founded
- AMD 1969
- ABBV 2012
- Country
- AMD United States
- ABBV United States
- Employees
- AMD N/A
- ABBV N/A
- Industry
- AMD Semiconductors
- ABBV Biotechnology: Pharmaceutical Preparations
- Sector
- AMD Technology
- ABBV Health Care
- Exchange
- AMD Nasdaq
- ABBV Nasdaq
- Market Cap
- AMD 351.2B
- ABBV 403.2B
- IPO Year
- AMD 1972
- ABBV N/A
- Fundamental
- Price
- AMD $253.59
- ABBV $215.31
- Analyst Decision
- AMD Buy
- ABBV Buy
- Analyst Count
- AMD 34
- ABBV 20
- Target Price
- AMD $218.06
- ABBV $233.89
- AVG Volume (30 Days)
- AMD 70.4M
- ABBV 5.4M
- Earning Date
- AMD 11-04-2025
- ABBV 10-31-2025
- Dividend Yield
- AMD N/A
- ABBV 3.27%
- EPS Growth
- AMD 107.70
- ABBV N/A
- EPS
- AMD 1.73
- ABBV 1.32
- Revenue
- AMD $29,600,000,000.00
- ABBV $59,644,000,000.00
- Revenue This Year
- AMD $29.47
- ABBV $10.00
- Revenue Next Year
- AMD $26.80
- ABBV $9.17
- P/E Ratio
- AMD $149.77
- ABBV $160.50
- Revenue Growth
- AMD 27.17
- ABBV 7.40
- 52 Week Low
- AMD $76.48
- ABBV $163.81
- 52 Week High
- AMD $267.08
- ABBV $244.81
- Technical
- Relative Strength Index (RSI)
- AMD 65.06
- ABBV 37.38
- Support Level
- AMD $253.41
- ABBV $212.06
- Resistance Level
- AMD $267.08
- ABBV $229.65
- Average True Range (ATR)
- AMD 9.07
- ABBV 4.23
- MACD
- AMD -0.66
- ABBV -2.27
- Stochastic Oscillator
- AMD 68.03
- ABBV 15.66
About AMD Advanced Micro Devices Inc.
Advanced Micro Devices designs a variety of digital semiconductors for markets such as PCs, gaming consoles, data centers (including artificial intelligence), industrial, and automotive applications. AMD's traditional strength was in central processing units and graphics processing units used in PCs and data centers. However, AMD is emerging as a prominent player in AI GPUs and related hardware. Additionally, the firm supplies the chips found in prominent game consoles such as the Sony PlayStation and Microsoft Xbox.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.